The MarketWatch News Department was not involved in the creation of this content.

Sep 17, 2020 (Global QYResearch via COMTEX) —
The study on Remote Diagnostics Devices market provides analysis of Global market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in Global market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis.

This the global Remote Diagnostics Devices market report is a valuable source of information for investors, new entrants, stakeholders and market players to formulate strategies for growth & expansion and obtain a competitive edge in the coming years.

Get Sample Copy of this [email protected] https://www.acumenresearchandconsulting.com/request-sample/853

Major players operating in the global Remote Diagnostics Devices market are focusing on some key market

Read More

Investors in GenMark Diagnostics, Inc. GNMK need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 16, 2020 $20.00 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for GenMark Diagnostics shares, but what is the fundamental picture for the

Read More

Investors in GenMark Diagnostics, Inc. (Symbol: GNMK) saw new options become available this week, for the April 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GNMK options chain for the new April 2021 contracts and identified one put and one call contract of particular interest.

The put contract at the $15.00 strike price has a current bid of $3.90. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $15.00, but will also collect the premium, putting the cost

Read More

Accomplished Medical Device and Pharma Executive Brings Proven Record
of Building Value in Life Science Companies

TORONTO, Aug. 18, 2020 /PRNewswire/ – SQI Diagnostics, Inc. (“SQI” or the “Company“) (TSX-V: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that the Company’s board of directors has appointed Robert L. Chioini as Chief Executive Officer and a director of the Company effective August 17, 2020.

“Rob is a successful entrepreneur and experienced CEO who has an exceptional track record of identifying and developing new product and revenue stream opportunities,” stated Mr. Clive J. Beddoe, Chairman of the Board of SQI. “His experience in marketing and commercializing novel products to capture market share and strengthen company brand will be invaluable as we advance our product portfolio, including our COVID19 severity assessment

Read More